Review highlights hypoxic preconditioning's protective effects in various diseases, suggesting potential therapeutic strategies.
Hypoxic Preconditioning (HPC) describes the phenomenon whereby brief, non-lethal hypoxic episodes enhance cellular resilience to subsequent severe hypoxia. Initially recognized in altitude studies, HPC has since been linked to broad protective effects, particularly in the protection of ischemia/hypoxia. This article highlights the biological rationale, potential mechanisms and applications, while addressing the challenges of clinical translation. As a form of endogenous adaptation, HPC offers a promising paradigm for preventive and therapeutic strategies across various diseases.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: